auryxia 210 mg:Label: AURYXIA

Label: AURYXIA

Label: AURYXIA

Auryxiaisindicatedforthecontrolofserumphosphoruslevelsinadultpatientswithchronickidneydiseaseondialysis.1.2IronDeficiencyAnemiainChronic ...。其他文章還包含有:「Auryxia(FerricCitrateTablets):Uses」、「Auryxia(ferriccitrate):Uses」、「AuryxiaDosageGuide」、「AuryxiaOral:Uses,SideEffects,Interactions」、「AuryxiaUses」、「Auryxia」、「AURYXIA®(ferriccitrate)」

查看更多 離開網站

Provide From Google
Auryxia (Ferric Citrate Tablets): Uses
Auryxia (Ferric Citrate Tablets): Uses

https://www.rxlist.com

Auryxia (ferric citrate) is a phosphate binder used for the control of serum phosphorus levels in patients with chronic kidney disease on dialysis.

Provide From Google
Auryxia (ferric citrate): Uses
Auryxia (ferric citrate): Uses

https://www.goodrx.com

Iron deficiency anemia in people with advanced kidney disease: The typical starting dose is 1 tablet (210 mg total dose) by mouth three times a day with meals.

Provide From Google
Auryxia Dosage Guide
Auryxia Dosage Guide

https://www.drugs.com

​The recommended starting dose is 2 tablets, swallowed whole, 3 times per day with meals. Auryxia tablets must not be chewed or crushed because ...

Provide From Google
Auryxia Oral: Uses, Side Effects, Interactions
Auryxia Oral: Uses, Side Effects, Interactions

https://www.webmd.com

Ferric citrate is used to lower high blood phosphate levels in people who are on dialysis due to severe kidney disease. Dialysis removes some phosphate from ...

Provide From Google
Auryxia Uses
Auryxia Uses

https://www.drugs.com

Auryxia is used to control phosphorus levels in adults with chronic kidney disease who are on dialysis. Auryxia is also used to treat iron ...

Provide From Google
Auryxia
Auryxia

https://www.drugs.com

Auryxia is a phosphate binder indicated for the control of serum phosphorus levels in adult patients with chronic kidney disease on dialysis. (1).

Provide From Google
AURYXIA® (ferric citrate)
AURYXIA® (ferric citrate)

https://www.auryxia.com

Learn more about FDA-approved AURYXIA® (ferric citrate), iron deficiency anemia (IDA) and hyperphosphatemia (HP).